Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-25-301033

Director acquired 5,340 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vieser Jaime Director 2025-11-21 Grant or award +5,340 $3.16 $16,874 26,499 D
Loading xslF345X05/ownership.xml…